National ALS Registry

National ALS Registry
Name	National ALS Registry
Purpose	To collect and analyze data on amyotrophic lateral sclerosis in the United States
Region served	United States
Language	English

National ALS Registry. The National ALS Registry is a comprehensive program established to gather critical information on individuals living with amyotrophic lateral sclerosis across the United States. Managed by the Centers for Disease Control and Prevention through its Agency for Toxic Substances and Disease Registry, it represents the nation's only population-based registry for this disease. The initiative aims to better understand the epidemiology of ALS, identify potential risk factors, and improve care for patients.

Overview

The registry was authorized by the ALS Registry Act, which was signed into law in 2008 following advocacy from organizations like the ALS Association. It is a critical tool for public health surveillance of a disease that affects nerve cells in the brain and spinal cord. By creating a national database, researchers can study the incidence and prevalence of ALS across diverse populations and geographic regions, including states like California and Texas. The program represents a significant collaboration between federal agencies, academic institutions, and patient advocacy groups.

Purpose and goals

The primary purpose is to estimate the number of new and existing cases of ALS annually within the United States. A key goal is to examine potential risk factors, such as environmental exposures, military service, and occupational history, which have been subjects of studies by institutions like the National Institutes of Health. The registry also aims to facilitate research by notifying participants about clinical trials and studies, thereby accelerating the work of organizations like the Muscular Dystrophy Association. Ultimately, it seeks to improve the quality of life and care standards for those affected by the disease.

Data collection and sources

Data collection utilizes a two-pronged approach to ensure a more complete picture. First, it employs administrative data from national databases like Medicare, the Veterans Health Administration, and the Veterans Benefits Administration to identify potential cases. Second, it incorporates self-enrollment through a secure web portal, allowing individuals to provide detailed information on their health history and exposures. This methodology helps mitigate underreporting and creates a robust dataset for analysis by researchers at entities such as the Mayo Clinic and Harvard University.

Research and findings

Research generated has produced important findings regarding the epidemiology of ALS. Reports have provided updated estimates of prevalence and incidence, noting higher rates among whites, males, and individuals over 60. Studies have explored associations with factors like smoking, pesticide exposure, and service in the Gulf War. The registry has enabled large-scale research projects, including work led by the Department of Veterans Affairs, and has been cited in publications like the Morbidity and Mortality Weekly Report. These insights guide public health strategies and future investigations.

Participation and enrollment

Participation is open to any individual diagnosed with ALS residing in the United States or its territories, such as Puerto Rico. Enrollment is conducted primarily online via a secure portal, with telephone assistance available. The process involves consenting to share health information and completing a series of risk factor surveys. Participants may be contacted about relevant research opportunities, including clinical trials sponsored by Biogen or Cytokinetics. The confidentiality of all data is protected under the Privacy Act of 1974.

Governance and funding

Governance and oversight are provided by the Agency for Toxic Substances and Disease Registry, a branch of the Centers for Disease Control and Prevention. Funding is appropriated by the United States Congress and has been supported through advocacy efforts by groups like the ALS Therapy Development Institute. An external review board, which may include representatives from institutions like Johns Hopkins University, provides scientific guidance. The program's operations and research priorities are regularly evaluated to ensure alignment with public health goals.

Category:Medical registries Category:Neurology Category:Public health in the United States